MedPath
HSA Approval

DEXTROSE INJECTION USP 70%

SIN10166P

DEXTROSE INJECTION USP 70%

DEXTROSE INJECTION USP 70%

October 6, 1998

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

V06DC01

glucose

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE CORPORATION

Active Ingredients

DEXTROSE ANHYDROUS 63.64 g/100 ml EQV DEXTROSE HYDROUS

70 g/100 ml

D-glucose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXTROSE INJECTION USP 70% - HSA Approval | MedPath